National Reference Laboratory- the Irish Experience Rosemarie - - PowerPoint PPT Presentation

national reference laboratory the irish
SMART_READER_LITE
LIVE PREVIEW

National Reference Laboratory- the Irish Experience Rosemarie - - PowerPoint PPT Presentation

WGS as a surveillance tool in the National Reference Laboratory- the Irish Experience Rosemarie Slowey 25th April 2019 State Veterinary Service Introduction of WGS in the AMR NRL Began in 2016 Illumina Miseq shared with NRLs for


slide-1
SLIDE 1

WGS as a surveillance tool in the National Reference Laboratory- the Irish Experience

Rosemarie Slowey 25th April 2019

slide-2
SLIDE 2

State Veterinary Service

slide-3
SLIDE 3

Introduction of WGS in the AMR NRL

  • Began in 2016
  • Illumina Miseq – shared with NRLs for

Campylobacter, Salmonella, Listeria, S. aureus and E. coli as well as virology division

  • Aim: implementation of WGS as a routine typing

tool

  • Initial setup – postdoc from University College

Dublin, support from Illumina

slide-4
SLIDE 4

WGS Workflow

DNA Extraction

  • Ultraclean microbial DNA isolation kit
  • MagNa Pure (Gram negative)

Library prep • Nextera XT → Flex kit Sequencing • V3 kit Assembly

  • Bionumerics

Analysis

  • Bionumerics, Blast, CGE tools
slide-5
SLIDE 5

Staff

  • 2 Laboratory analysts, 1 research
  • fficer
  • Training from Illumina, Applied

Maths, EURLs To date 10 Campylobacter, 35 Enterococcus, 250 E. coli and 220 Salmonella sequenced

Initial Challenges

  • Clustering related to DNA extraction

method for Gram negatives

  • Issues with Qubit calibration
  • IT security issues – FTP, Basespace,

CGE access

  • New server- data storage
  • Computer upgrades required
  • Bionumerics affected by network

speed

slide-6
SLIDE 6

Why do we use WGS?

  • 1. To validate results of AST testing before

inclusion in EUSR/ national one health report

  • 2. To assess trends and screen for emerging

genotypes

  • 3. To contribute towards enhanced AMR

surveillance (National Action Plan)

  • 4. To provide more robust data to inform

stakeholders-colleagues formulating policy, prescribing vets and farmers

slide-7
SLIDE 7

To validate results of AST testing

High IMI/ ETR/TEM MIC blaCMY-2 or Amp C promoter region mutations ESBL genes present in all 13 isolates 11x bla CTX-M- 1 2 x bla SHV-2

  • S. Orion

CTX, Caz Res No ESBL genes Identified No ESBL genes Identified in 4

  • f 156

presumptive positive ESBL E. coli

slide-8
SLIDE 8

EUSR 2016 - prevalence of ESBL-producing E. coli from broilers

To assess trends

Proportion of broiler caecalsamples positive for presumptive ESBL- producing E. coli

slide-9
SLIDE 9

ESBLs in broiler E. coli isolates

blaSHV-12 isolates blaCTX-M-1 isolates

BlaCTX-M-1 and BlaSHV-12 predominated, with diverse ST-types

slide-10
SLIDE 10

blaCTX-M-1(n=69) blaSHV-12 (n=20) IncI1 94 50 ST-3 84 ST26 or 36 35 IncF 74 65 F43:A:B- 15

ESBLs in broiler E. coli isolates ctd.

blaCTX-M-1

  • 50% CTX-M-15+ Sul2+Tet(A)
  • 57% aadA5/ dfrA17 class 1

integron BlaSHV-1

  • 66%- QnrS1

No O1/ O2/O78 strains 37% of 2018 isolates EAST-1 positive % isolates containing IncI1 and IncF Plasmids

slide-11
SLIDE 11

Current situation

slide-12
SLIDE 12

EUSR 2017 - prevalence of ESBL-producing E. coli from fattening pigs

To screen for emerging genotypes

  • Prevalence of ESBL-

producing E. coli lower in pigs (18%)

  • Prevalence of blaCTX-

M-15 in pig E. coli increased from 2015 to 2017

  • No ST131
  • blaCTX-M-15

associated with ISEcp1

  • Variable resistance

gene combinations

  • IncF, IncY, Col

plasmids

slide-13
SLIDE 13

To provide more robust data to inform stakeholders-case study

History : Beef suckler herd of 50 - 60 cows and calves lost 11 cows and 31 calves between 2015-17 Presentation : enteritis in young calves, post caesarean infections unresponsive to antimicrobial treatment Post- mortem findings- MDR E. coli isolated from internal organs and faeces Was this the cause of mortality? Treatment options?

slide-14
SLIDE 14

WGS Results ST-10 – WGS Virulence factors: F17a ST-88 with mutations in the AmpC promoter region Virulence Factors: EAST-1, CS31A ,

microcin M part of colicin H, siderophore receptors, extracellular serine protease and increased serum survival, adherence protein and long polar fimbrae.

Phenotype 1 isolate 3 Isolates Amp-C Phenotype

AMP-CHL-CIP-GEN-NAL-SMX-TET-TMP AMP-CTX-CAZ-CIP-CHL-GEN-NAL-SMX-TET-TMP

slide-15
SLIDE 15

Where has WGS been most useful in our lab?

  • Rapid confirmation of genotypes from assemblies
  • More efficient than AST testing of less common and

fastidious bacteria (Pasteurella multocida)

  • Less time consuming than individual ESBL PCRs +

Sanger sequencing

  • Additional information- not just AMR
  • Provides information on what resistance genes are-

and are not circulating

slide-16
SLIDE 16

The Challenges

  • QC of data without

bioinformatician

  • What to do with “grey hits”?
  • Still takes 7 working days from

culture to assembled files

  • Failed runs
  • Extra costs- software and

contracts

Entry N50 NrContigs AvgDeNovoCover Length 1 69596 161 73.0 2875005 2 30240 450 53.9 5468620 3 15971 983 35.7 5369509 4 5063 2772 34.5 6172247 5 54598 213 89.2 2712757

slide-17
SLIDE 17

Final Thoughts

  • WGS EQAS like GMI PT will be

essential

  • No hits ≠ no resistance genes
  • Support will be required from

EURL

  • Amount of information can be
  • verwhelming
slide-18
SLIDE 18

Acknowledgements

Thanks to my colleagues in the AMR NRL and the veterinary laboratory service, DAFM.